ID | Symbol | Common_Name | Chemical_Formula | Nucleoside_Mass | Description |
1 | 1mA | 1-methyladenine | C6H7N5 | 149.16 | Adenine substituted with a methyl group at position N-1. |
2 | 3mA | 3-methyladenine | C6H7N5 | 149.16 | A methyladenine that is adenine substituted with a methyl group at position N-3. |
3 | 4mA | 4-methyladenine | C6H9N5 | 151.17 | A methyladenine in which the methyl substituent is located at position 4. |
4 | 6mA | 6-methyladenine | C6H7N5 | 149.16 | A methyladenine that is 9H-purin-6-amine substituted by a methyl group at the amino nitrogen. |
5 | 7mA | 7-methyladenine | C6H7N5 | 149.16 | Adenine substituted with a methyl group at position N-7. |
6 | 9mA | 9-methyladenine | C6H7N5 | 149.16 | Adenine substituted with a methyl group at position N-9. |
7 | 6hmA | 6-hydroxymethyladenine | C6H7N5O | 165.16 | A 6-alkylaminopurine that is adenine where one of the hydrogens of the amino group is replaced by a hydroxymethyl group. |
8 | HAP | 6-hydroxyaminopurine | C5H5N5O | 151.13 | A member of the class of 6-aminopurinnes that is adenine in which one of the exocyclic amino hydrogens is replaced by a hydroxy group. |
9 | m2A | 2-aminoadenine | C5H6N6 | 150.15 | A member of the class of 2,6-diaminopurines that is 9H-purine in which the hydrogens at positions 2 and 6 are replaced by amino groups. |
10 | AHAP | 2-amino-6-hydroxyaminopurine | C5H6N6O | 166.14 | A 2,6-diaminopurine that is the N(6)-hydroxy derivative of 2,6-diamino-3H-purine. |
11 | 6-DMA | N6,N6-dimethyladenine | C7H9N5 | 163.18 | A tertiary amine that is adenine substituted at N-6 by geminal methyl groups. |
12 | ncm6A | N6-carbamoylmethyladenine | C7H8N6O | 192.18 | A nucleobase analogue that is adenine in which one of the exocyclic amino hydrogens is replaced by a carbamoylmethyl group. |
13 | ɛA | 1,N6-ethenoadenine | C7H6N5+ | 160.16 | |
14 | 1mG | 1-methylguanine | C6H7N5O | 165.16 | Guanosine substituted with a methyl group at position N-1 |
15 | 2mG | 2-methylguanine | C6H7N5O | 165.16 | A methylguanine in which the methyl group is located at the N2-position. |
16 | 3mG | 3-methylguanine | C6H7N5O | 165.16 | A methylguanine carrying the methyl substituent at position 3. |
17 | m6G | 6-O-methylguanine | C6H7N5O | 165.16 | A methylguanine in which the methyl group is positioned on the oxygen at position 6. |
18 | 7mG | 7-methylguanine | C6H7N5O | 165.16 | A methylguanine that is guanine substituted by a methyl group at position 7. |
19 | 8-oxo-G | 8-oxoguanine | C5H3N5O2 | 165.11 | An oxopurine that is guanine which is substituted by an oxo group at position 8. |
20 | ADG | 7-amido-7-deazaguanosine | C12H15N5O6 | 325.28 | A 7-deazaguanosine ribonucleoside that has 7-carbamoyl-7-deazaguanine as the nucleobase. |
21 | 1,N(2)-ɛG | 1,N2-ethenoguanine | C7H5N5O | 175.15 | A nucleobase analogue obtained by addition of an etheno group across positions 1 and N2 of guanine. |
22 | N(2),3-ɛG | N2,3-ethenoguanine | C7H5N5O | 175.15 | A nucleobase analogue obtained by addition of an etheno group across positions N2 and 3 of guanine. |
23 | m22G | N2,N2-dimethylguanosine | C12H17N5O5 | 311.3 | A guanosine where the hydrogens of the amine group at C-2 are substituted by methyl groups. |
24 | CEG | N2-carboxyethylguanine | C8H9N5O3 | 223.19 | An alanine derivative consisting of alanine having a 6-oxo-6,9-dihydro-1H-purin-2-yl group attached to the amino function. |
25 | 1mC | 1-methylcytosine | C5H7N3O | 125.13 | A pyrimidone that is cytosine in which the hydrogen attached to the nitrogen at position 1 is substituted by a methyl group. |
26 | m2C | 2-O-methylcytosine | C5H7N3O | 125.13 | Pyrimidine substituted with a methoxy group at position C-2 and an amine group at C-4. |
27 | e3C | 3-ethylcytosine | C6H9N3O | 139.16 | A pyrimidone that is cytosine substituted by an ethyl group at position 3. |
28 | 3mC | 3-methylcytosine | C5H7N3O | 125.13 | A pyrimidone that is cytosine in which the hydrogen attached to the nitrogen at position 3 is substituted by a methyl group. |
29 | ɛC | 3,N4-ethenocytosine | C6H5N3O | 135.12 | |
30 | 4mC | 4-methylcytosine | C5H7N3O | 125.13 | A pyrimidone that is cytosine bearing an N(4)-methyl substituent. |
31 | 5caC | 5-carboxylcytosine | C5H5N3O3 | 155.11 | A nucleobase analogue that is cytosine in which the hydrogen at position 5 is replaced by a carboxy group. |
32 | 5fC | 5-formylcytosine | C5H5N3O2 | 139.11 | A nucleobase analogue that is cytosine in which the hydrogen at position 5 is replaced by a formyl group. |
33 | 5hmC | 5-hydroxymethylcytosine | C5H7N3O2 | 141.13 | A nucleobase analogue that is cytosine in which the hydrogen at position 5 is replaced by a hydroxymethyl group. |
34 | 5gmC | 5-glucosylmethylcytosine | C11H17N3O7 | 303.27 | A beta-D-glucoside derived from formal condensation of the hydroxy group of 5-(hydroxymethyl)cytosine with the anomeric hydroxy group of D-glucopyranose. |
35 | 5mC | 5-methylcytosine | C5H7N3O | 125.13 | A pyrimidine that is a derivative of cytosine, having a methyl group at the 5-position. |
36 | putThy | α-putrescinylthymine | C9H16N4O2 | 212.25 | An N-substituted putrescine that is thymine in which a hydrogen of the methyl group has been replaced by one of the amino groups of putrescine. |
37 | 1mT | 1,5-dimethyluracil | C6H8N2O2 | 140.14 | A pyrimidone that is uracil with methyl group substituents at positions 1 and 5 |
38 | 3mT | 3,5-dimethyluracil | C6H8N2O2 | 140.14 | A pyrimidone that is uracil with methyl group substituents at positions 3 and 5 |
39 | O4-meT | O(4)-methylthymine | C6H8N2O2 | 140.14 | A methylthymine in which the methyl group is located at the O4-position |
40 | diHT | 5,6-dihydrothymine | C5H8N2O2 | 128.13 | A pyrimidone obtained by formal addition of hydrogen across the 5,6-position of thymine. |
41 | 5hmU | 5-hydroxymethyluracil | C5H6N2O3 | 142.11 | A primary alcohol that is uracil bearing a hydroxymethyl substituent at the 5-position. |
42 | 5fU | 5-formyluracil | C5H4N2O3 | 140.1 | A pyrimidone resulting from the formal oxidation of the alcoholic hydroxy group of 5-hydroxymethyluracil to the corresponding aldehyde. It is a major one-electron photooxidation product of thymine in oligodeoxynucleotides. |
43 | base J | (beta-D-glucopyranosyloxymethyl)deoxyuridine 5'-monophosphate | C16H25N2O14P | 500.35 | A pyrimidine 2'-deoxyribonucleoside 5'-monophosphate having beta-D-glucopyranosyloxymethyluracil (base J) as the nucleobase |
44 | dhpUra | 5-(4,5-dihydroxypentyl)uracil | C9H14N2O4 | 214.22 | A nucleobase analogue that is uracil substituted at position 5 by a 4,5-dihydroxypentyl group. |
45 | 5caU | uracil-5-carboxylic acid | C5H4N2O4 | 156.1 | |
46 | 5-NeOmdU | 5-(2-aminoethoxy)methyl-2'-deoxyuridine | C12H19N3O6 | 301.3 | A pyrimidine 2'-deoxyribonucleoside that is 5-hydroxymethyl-2'-deoxyuridine in which the hydroxymethyl group at position 5 has been formally converted to the corresponding 2-aminoethyl ether. It is a thymidine hypermodification replacing 40% of thymidine nucleotides in the Salmonellaphage ViI. |
47 | dU | 2'-deoxyuridine | C9H12N2O5 | 228.2 | A pyrimidine 2'-deoxyribonucleoside having uracil as the nucleobase |
48 | DHdU | 5,6-dihydroxy-2'-deoxyuridine | C9H12N2O7 | 260.2 | A pyrimidine 2'-deoxyribonucleoside having 5,6-dihydroxyuracil as the nucleobase |
49 | 5-NedU | 5-(2-aminoethyl)-2'-deoxyuridine | C11H17N3O5 | 271.27 | A pyrimidine 2'-deoxyribonucleoside that is 2'-deoxyuridine in which the hydrogen at position 5 has been replaced by a 2-aminoethyl group. It is a thymidine hypermodification replacing 30% of thymidine in the DNA of the Pseudomonas phage M6. |
50 | dhpdU | 2'-deoxy-5-(4,5-dihydroxypentyl)uridine | C14H22N2O7 | 330.34 | A pyrimidine 2'-deoxyribonucleoside having 5-(4,5-dihydroxypentyl)uracil as the nucleobase |
51 | dI | 2'-deoxyinosine | C10H12N4O4 | 252.23 | A purine 2'-deoxyribonucleoside that is inosine in which the hydroxy group at position 2' is replaced by a hydrogen |